Evidence mapPaperPMID 40401174Full record

ArticleJCEM case reports2025

The Challenge of Type 3c Diabetes: From Accurate Diagnosis to Effective Treatment.

Ilaria Milani, Gloria Guarisco, Marianna Chinucci, Chiara Gaita, Frida Leonetti, Danila Capoccia

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Pancreatic Cancer and Diabetes: Insights, Hypotheses, and Next Steps.International journal of molecular sciences · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ilaria MilaniFaculty of Pharmacy and Medicine, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latin 04100, Italy.ORCID https://orcid.org/0009-0004-0120-4731
Gloria GuariscoFaculty of Pharmacy and Medicine, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latin 04100, Italy.
Marianna ChinucciFaculty of Pharmacy and Medicine, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latin 04100, Italy.
Chiara GaitaFaculty of Pharmacy and Medicine, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latin 04100, Italy.
Frida LeonettiFaculty of Pharmacy and Medicine, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latin 04100, Italy.ORCID https://orcid.org/0000-0002-5606-8448
Danila CapocciaFaculty of Pharmacy and Medicine, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latin 04100, Italy.ORCID https://orcid.org/0000-0003-1674-6686

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 3c diabetes mellitus is a secondary form of diabetes associated with pancreatic disease, primarily chronic pancreatitis, which impairs insulin and glucagon secretion, resulting in inadequate glycemic control. Often misdiagnosed as other types of diabetes, such as type 1 or type 2 diabetes mellitus, type 3c diabetes mellitus is characterized by significant glucose variability, increased insulin requirements, and risk of hypoglycemia. This case report describes a 24-year-old man with a history of hereditary chronic pancreatitis resulting from a serine protease 1 (

Indexed as

chronic pancreatitisdiagnosisglucose monitoringtreatmenttype 3c diabetes mellitus

Identifiers

PMID40401174
PMCPMC12093095

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.